Dr. Robert Hecht is Principal and Managing Director at Results for Development Institute, a Washington, D.C.-based nonprofit that works on health, development, and education issues. He is editor of the just-published “Costs and Choices: Financing the Long-Term Fight Against AIDS,” an aids2031 project. Hecht spoke with John Donnelly about the recent UNAIDS report that showed […]
In the lead up to this week’s MDG Summit, health experts discussed integration of HIV/AIDS programs with other health programs at a special event in Washington, DC. David Hoos, MD, of Columbia University’s International Center for AIDS Care and Treatment Programs (ICAP), one of the largest PEPFAR implementers, spoke on the panel, which was sponsored […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]